Empagliflozin Versus Linagliptin in Renal Ransplant Recipients With Diabetes Mellitus

Clinical trial NCT06098625 · UNKNOWN

Trial details

NCT number: NCT06098625
Sponsor: Medanta, The Medicity, India
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Diabetes Mellitus Kidney Transplant; Complications

Start date: 2023-11-10
Primary completion: 2025-07-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.